Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Nehme El-Hachem
Affiliation
Centre Hospitalier Universitaire Sainte-Justine Research Centre
ORCID
Career Start Year
2011
Papers
47
H Index
16
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37776054
Intratumoral administration of unconjugated Accumâ¿¢ impairs the growth of pre-established solid lymphoma tumors.
Cancer Sci
2023
37776054
Intratumoral administration of unconjugated Accumâ¿¢ impairs the growth of pre-established solid lymphoma tumors.
Cancer Sci
2023
35203247
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes.
Cells
2022
35681511
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress Response.
Cells
2022
35795568
Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening.
Front Pharmacol
2022
35544595
Acute inflammatory response via neutrophil activation protects against the development of chronic pain.
Sci Transl Med
2022
36437872
The <i>CIt</i> protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells.
iScience
2022
35203247
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes.
Cells
2022
35012668
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells.
Stem Cell Res Ther
2022
35544595
Acute inflammatory response via neutrophil activation protects against the development of chronic pain.
Sci Transl Med
2022
35795568
Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening.
Front Pharmacol
2022
35681511
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress Response.
Cells
2022
36437872
The <i>CIt</i> protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells.
iScience
2022
35012668
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells.
Stem Cell Res Ther
2022
32881655
Repurposing Cilostazol for Raynaud's Phenomenon.
Curr Med Chem
2021
33542714
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity <i>via</i> Cross-Priming of Endogenous Dendritic Cells.
Front Immunol
2021
32881655
Repurposing Cilostazol for Raynaud's Phenomenon.
Curr Med Chem
2021
33087510
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity.
Mol Cancer Ther
2021
35028603
Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice.
Cell Rep Med
2021
33542714
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity <i>via</i> Cross-Priming of Endogenous Dendritic Cells.
Front Immunol
2021
35028603
Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice.
Cell Rep Med
2021
33087510
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity.
Mol Cancer Ther
2021
32231565
A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties.
Front Pharmacol
2020
32350852
A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans.
Clin Genet
2020
32231565
A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties.
Front Pharmacol
2020
33103068
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal.
iScience
2020
32937114
Assessment of Genetic Drift in Large Pharmacogenomic Studies.
Cell Syst
2020
32968641
A comparison of artificial intelligence-based algorithms for the identification of patients with depressed right ventricular function from 2-dimentional echocardiography parameters and clinical features.
Cardiovasc Diagn Ther
2020
33103068
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal.
iScience
2020
32968641
A comparison of artificial intelligence-based algorithms for the identification of patients with depressed right ventricular function from 2-dimentional echocardiography parameters and clinical features.
Cardiovasc Diagn Ther
2020
32937114
Assessment of Genetic Drift in Large Pharmacogenomic Studies.
Cell Syst
2020
32350852
A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans.
Clin Genet
2020
30763288
Genetic pathway analysis reveals a major role for extracellular matrix organization in inflammatory and neuropathic pain.
Pain
2019
31696161
<i>gem</i>-Difluorobisarylic derivatives: design, synthesis and anti-inflammatory effect.
BMC Chem
2019
30763288
Genetic pathway analysis reveals a major role for extracellular matrix organization in inflammatory and neuropathic pain.
Pain
2019
31007848
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer.
Oncotarget
2019
31198954
SIGN: similarity identification in gene expression.
Bioinformatics
2019
31696161
<i>gem</i>-Difluorobisarylic derivatives: design, synthesis and anti-inflammatory effect.
BMC Chem
2019
31198954
SIGN: similarity identification in gene expression.
Bioinformatics
2019
31007848
AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer.
Oncotarget
2019
29016819
Tissue specificity of in vitro drug sensitivity.
J Am Med Inform Assoc
2018
29016819
Tissue specificity of in vitro drug sensitivity.
J Am Med Inform Assoc
2018
30053271
PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.
Nucleic Acids Res
2018
30425966
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the <i>TBX2</i> Subfamily of Tumor Suppressor Genes.
Front Oncol
2018
29317617
Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
Nat Commun
2018
30053271
PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.
Nucleic Acids Res
2018
30425966
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the <i>TBX2</i> Subfamily of Tumor Suppressor Genes.
Front Oncol
2018
29317617
Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
Nat Commun
2018
28508374
AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study.
Methods Mol Biol
2017
28469241
A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases.
Sci Rep
2017
1 - 50 of 94
Column Actions
Search
Recommended Authors
Lang Li
College of Medicine, The Ohio State University
Career Start Year
2018
Number of shared co-authors
0
Shuyu Zheng
University of Helsinki
Career Start Year
2016
Number of shared co-authors
0
Shraddha Thakkar
Center for Drug Evaluations and Research (CDER)
Career Start Year
2013
Number of shared co-authors
3
Bhavneet Bhinder
Memorial Sloan Kettering Cancer Center, USA Memorial Sloan Kettering Cancer Center
Career Start Year
2010
Number of shared co-authors
0
Daniel D'Andrea
Nottingham Trent University
Career Start Year
2010
Number of shared co-authors
0
Murat Iskar
Friedrich Miescher Institute for Biomedical Research
Career Start Year
2010
Number of shared co-authors
0
Andrew T Magis
Institute for Systems Biology
Career Start Year
2007
Number of shared co-authors
0
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year
2006
Number of shared co-authors
0
Guan Wang
Jilin University
Career Start Year
2005
Number of shared co-authors
0
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year
2003
Number of shared co-authors
1
Mandeep Kaur
Post Graduate Institute of Medical Education and Research
Career Start Year
2003
Number of shared co-authors
1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year
2003
Number of shared co-authors
0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year
2003
Number of shared co-authors
0
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year
2003
Number of shared co-authors
0
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
0
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
4
Sunkyu Kim
Korea University
Career Start Year
2000
Number of shared co-authors
0
Tero Aittokallio
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year
1999
Number of shared co-authors
3
Liewei Wang
Mayo Clinic
Career Start Year
1999
Number of shared co-authors
1
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year
1998
Number of shared co-authors
1
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Career Start Year
1998
Number of shared co-authors
0
Andrey Loboda
Merck & Co., Inc.
Career Start Year
1998
Number of shared co-authors
1
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year
1998
Number of shared co-authors
1
Bissan Al-Lazikani
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
2
Krister Wennerberg
University of Copenhagen
Career Start Year
1994
Number of shared co-authors
1
Shireen Vali
Cellworks Group Inc.
Career Start Year
1994
Number of shared co-authors
0
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year
1992
Number of shared co-authors
0
Christopher P Austin
St. George's University Medical School
Career Start Year
1990
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
23
Zhaleh Safikhani
Princess Margaret Cancer Center, University Health Network
Co-authored papers
12
Moutih Rafei
Universite de Montreal
Co-authored papers
11
Hugo J W L Aerts
Harvard Medical School
Co-authored papers
10
Anna Goldenberg
SickKids Research Institute
Co-authored papers
6
John Quackenbush
Harvard T. H. Chan School of Public Health
Co-authored papers
6
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers
6
Deena M A Gendoo
Institute of Cancer and Genomic Sciences, University of Birmingham
Co-authored papers
3
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers
3
Seyed Ali Madani Tonekaboni
Princess Margaret Cancer Research Centre
Co-authored papers
2
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers
2
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers
2
No??l J-M Raynal
Sainte-Justine University Hospital Research Center
Co-authored papers
1
Ruth Isserlin
University of Toronto
Co-authored papers
1
Marcel Ramos
Graduate School of Public Health and Health Policy, City University of New York
Co-authored papers
1
Martin Morgan
Roswell Park Comprehensive Cancer Center
Co-authored papers
1
Emmanuel Rios Velazquez
Research Institute GROW, Maastricht University
Co-authored papers
1
Ming Shi
Co-authored papers
1
Levi Waldron
City University of New York School of Public Health
Co-authored papers
1
Robert Castelo
Universitat Pompeu Fabra (UPF)
Co-authored papers
1
Jonathan G Seidman
Harvard Medical School
Co-authored papers
1
Alexander Samoshkin
McGill University
Co-authored papers
1
Philippe Lambin
Maastricht University
Co-authored papers
1
Jacques Archambault
McGill University
Co-authored papers
1
Vincent J Carey
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
1
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Co-authored papers
1
David Gomez-Cabrero
King Abdullah University of Science and Technology
Co-authored papers
1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers
1
Susan R Davis
Co-authored papers
1
1 - 30